Imagion Biosystems Successfully Completes Toxicology Study

Imagion Biosystems Successfully Completes Toxicology Study

Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the successful completion of a toxicology safety study of its lead MagSense® nanoparticle formulation for the detection of HER2 metastatic breast cancer.
Read the announcement.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.